Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
& Anders, S
Kim GL, Song JG, Han HK
DOI: 10.3390/molecules27010324
M.AzeredoS.MonteiroE
doi: 10.3389/fmed.2022.875430 Summary Keywords glucagon-like peptide-1 receptor agonist (GLP-1RA), incretin based therapy, glucose-depent insulinotropic peptide (GIP), dual agonists, tirzepatide, type 2 diabetes Citation Gallwitz B (2022) Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity
US$ 21.06
US$ 25.95
US$ 23.06
US$ 28.79
US$ 21.60
